pharmatechoutlook
knowledge

The Past Decade of Quality by Design: A Perspective Overview
Pharmatechoutlook >> cxoinsights

Brad Swarbrick, Owner, Quality by Design Consultancy

In 2011 when the US Food and Drug Administration (US-FDA) published their guidance document on Process Validation (PV), this represented the first real attempt by a regulatory authority to mandate the implementation of the Quality by Design...

The Past Decade of Quality by Design: A Perspective Overview
Pharmatechoutlook >> cxoinsights

Brad Swarbrick, Owner, Quality by Design Consultancy

In 2011 when the US Food and Drug Administration (US-FDA) published their guidance document on Process Validation (PV), this represented the first real attempt by a regulatory authority to mandate the implementation of the Quality by Design...

The Past Decade of Quality by Design: A Perspective Overview
Pharmatechoutlook >> cxoinsights

Brad Swarbrick, owner, Quality by Design Consultancy

Introduction In 2011 when the US Food and Drug Administration (US-FDA) published their guidance document on Process Validation (PV), this represented the first real attempt by a regulatory authority to mandate the implementation of the Quality...

The Past Decade of Quality by Design: A Perspective Overview
Pharmatechoutlook >> cxoinsights

Brad Swarbrick, owner, Quality by Design Consultancy

Introduction In 2011 when the US Food and Drug Administration (US-FDA) published their guidance document on Process Validation (PV), this represented the first real attempt by a regulatory authority to mandate the implementation of the Quality...

STEER Utilizes Six Sigma Framework and Process Analytics for Better Medicine Practices
Pharmatechoutlook >> news

FREMONT, CA: STEER, the producer of the material and technology platform, introduces its new technology and solutions -STEERLIFE which aims to redesign the global pharmaceutical industry by modifying the nature of medicine previously made and...

Health Information Made Easy to Make People Healthier
Pharmatechoutlook >> cioviewpoint

Gray Knowlton, CIO, Upsher-Smith Laboratories

Big Challenge in Technology Our industry is moving toward individualized, targeted solutions for improving a person’s health. Aligning incentives with outcome-driven care is difficult in our current environment. Research toward...

Covering All Aspects of Analytics
Pharmatechoutlook >> cxoinsights

Paul Kallukaran, Executive Director, Global Commercial Business Analytics

When Merck IT decided to focus on analytics, the intent was clear – empower the company to identify insights and make data-driven decisions that have the potential to solve important problems and drive shareholder value. While the goal may...

Covering All Aspects of Analytics
Pharmatechoutlook >> cxoinsights

Paul Kallukaran, Executive Director, Global Commercial Business Analytics

When Merck IT decided to focus on analytics, the intent was clear – empower the company to identify insights and make data-driven decisions that have the potential to solve important problems and drive shareholder value. While the goal may...

81qd: Analytics to Improve Patient Outcomes
Pharmatechoutlook >> vendor

Bob Gabruk, Managing Director

Customized, cost-effective health care data analytics solutions to maximize the commercial potential of biopharmaceutical products. An advanced health care data analytics company whose offerings are customized, high-value, brand-specific,...

Excelra: Intelligent Analytics for Effective Drug Discovery
Pharmatechoutlook >> vendor

Anandbir Singh Brar, CEO

Excelera provides intelligent data and analytics solutions to life sciences and pharma organizations globally